- Prev Rank-
- LocationNew York, N.Y.
- IndustrySecurities
- SectorFinancial
- F1000 Rank-
- G500 Rank-
- Current Streak-
“Boutique” investment bank prospers as the return of M&A—it advised Shire in its sale to AbbVie and helped AstraZeneca fend off Pfizer—provided loads of deals.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Company Information
| Location | New York, N.Y. |
| Industry | Securities |
| Sector | Financial |
| Current Streak | - |
Revenue, Net Income
| Revenue Past Four Quarters | 776 |
| Net Income Past Four Quarters | 57.8 |
Growth Rates & Ranks
| EPS Growth Rank | 35 |
| EPS 3 yr Annual Growth Rate Pct | 67 |
| Revenue Growth Rank | 86 |
| Rev 3 yr Annual Growth Rate | 23 |
| Total Return 3 yr Annual Rate | 23 |
| Total Return Rank | 70 |
| Beat S&P 3 yr Annual Growth Rate? | yes |
| P/E current fiscal year profits (est.) | 22.1 |
